Nathan Keller
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 12
- Antifungal resistance and susceptibility 11
- Epidemiology 28
- Respiratory viral infections research 6
- Infective Endocarditis Diagnosis and Management 6
- Co-authors
- Yasmin Maor (8 shared papers)Juri Kopolovic (4 shared papers)Debby Ben-David (6 shared papers)Ana Tobar (4 shared papers)Gili Regev‐Yochay (6 shared papers)Galia Rahav (14 shared papers)Mati Fridkin (3 shared papers)Miri Blank (4 shared papers)
- Journals
- Journal of Clinical Microbiology (8 papers)The Pediatric Infectious Disease Journal (6 papers)Clinical Microbiology and Infection (4 papers)Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Nathan Keller
116 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 132
- Molecular Medicine 888
- Applied Microbiology and Biotechnology 272
- Infectious Diseases 1.4k
- Clinical Biochemistry 453
- Endocrinology 351
Countries citing papers authored by Nathan Keller
This map shows the geographic impact of Nathan Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Keller more than expected).
Fields of papers citing papers by Nathan Keller
This network shows the impact of papers produced by Nathan Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Keller. The network helps show where Nathan Keller may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 312 | |
| 2 | 2011 | 281 | |
| 3 | 2002 | 260 | |
| 4 | 2001 | 240 | |
| 5 | 2002 | 225 | |
| 6 | 2004 | 217 | |
| 7 | 2002 | 188 | |
| 8 | 2012 | 146 | |
| 9 | 2010 | 143 | |
| 10 | 2009 | 133 | |
| 11 | 2008 | 105 | |
| 12 | 2005 | 98 | |
| 13 | 1997 | 90 | |
| 14 | 2005 | 81 | |
| 15 | 2007 | 67 | |
| 16 | 2000 | 61 | |
| 17 | 2000 | 57 | |
| 18 | 2005 | 56 | |
| 19 | 2006 | 47 | |
| 20 | 1998 | 46 |
About Nathan Keller
Nathan Keller is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Medicine and Surgery, having authored 125 papers that have together received 4.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (13 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Antifungal resistance and susceptibility (11 papers), Streptococcal Infections and Treatments (9 papers), Bacterial Identification and Susceptibility Testing (9 papers), Bacterial Infections and Vaccines (7 papers), Respiratory viral infections research (6 papers) and Infective Endocarditis Diagnosis and Management (6 papers). The work is most often cited by research in Molecular Medicine (888 citations), Applied Microbiology and Biotechnology (272 citations), Infectious Diseases (1.4k citations), Clinical Biochemistry (453 citations) and Endocrinology (351 citations). Nathan Keller has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Yasmin Maor, Juri Kopolovic, Debby Ben-David, Ana Tobar, Gili Regev‐Yochay, Galia Rahav, Mati Fridkin, Miri Blank, Ilana Tal and Ilan Krause. Their work appears in journals such as Journal of Clinical Microbiology, The Pediatric Infectious Disease Journal, Clinical Microbiology and Infection, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.